{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:57:07Z","timestamp":1792421827795,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.semarthrit.2022.152150","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T02:22:22Z","timestamp":1670466142000},"page":"152150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution"],"prefix":"10.1016","volume":"58","author":[{"given":"Tim","family":"McEwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Bhambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-3418","authenticated-orcid":false,"given":"Philip C","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2022.152150_bib0001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/14656566.2015.997213","article-title":"Advances in Pharmacotherapy for the Treatment of Gout","volume":"16","author":"Robinson","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"19","key":"10.1016\/j.semarthrit.2022.152150_bib0002","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.semarthrit.2022.152150_bib0003","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152150_bib0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease","volume":"135","author":"Robinson","year":"2022","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152150_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092615","article-title":"Efficacy of Colchicine in the Treatment of Covid-19 Patients: a Systematic Review and Meta-Analysis","volume":"11","author":"Toro-Huamanchumo","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152150_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semarthrit.2020.11.007","article-title":"A Systematic Review of the Infectious Complications of Colchicine and the Use of Colchicine to Treat Infections","volume":"51","author":"McEwan","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152150_bib0007","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse Events During Oral Colchicine Use: a Systematic Review and Meta-Analysis of Randomised Controlled Trials","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152150_bib0008","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1592\/phco.24.17.1784.52334","article-title":"Colchicine Myotoxicity: case Reports and Literature Review","volume":"24","author":"Wilbur","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152150_bib0009","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A Method for Estimating the Probability of Adverse Drug Reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2022.152150_bib0010","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The Prisma Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Healthcare Interventions: explanation and Elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2022.152150_bib0011","series-title":"The flockhart cytochrome P450 drug-drug interaction table. division of clinical pharmacology","author":"Flockhart","year":"2021"},{"key":"10.1016\/j.semarthrit.2022.152150_bib0012","unstructured":"U.S. Food and Drug Administration. Drug Development and Drug Interactions. Table of Substrates, Inhibitors and Inducers (Updated 2020). https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers. Accessed [25\/02\/2022]."},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152150_bib0013","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3899\/jrheum.150310","article-title":"Dalbeth N. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population","volume":"42","author":"Robinson","year":"2015","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152150_bib0014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00000441-197603000-00014","article-title":"Massive Colchicine Overdose: a Report on the Toxicity","volume":"271","author":"Heaney","year":"1976","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152150_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0735-6757(98)90228-5","article-title":"Fatal Colchicine Overdose: report of a Case and Review of the Literature","volume":"16","author":"Milne","year":"1998","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152150_bib0016","first-page":"528","article-title":"Acute Toxicity after Excessive Ingestion of Colchicine","volume":"58","author":"Murray","year":"1983","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152150_bib0017","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00540-012-1531-2","article-title":"Severe Colchicine Intoxication after Self-Administration of Colchicine Concomitantly with Loxoprofen","volume":"27","author":"Yamazaki","year":"2013","journal-title":"J Anesth"},{"issue":"suppl_1","key":"10.1016\/j.semarthrit.2022.152150_bib0018","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","article-title":"Update on Colchicine, 2017","volume":"57","author":"Slobodnick","year":"2018","journal-title":"Rheumatology"},{"issue":"553","key":"10.1016\/j.semarthrit.2022.152150_bib0019","article-title":"Colchicine Myopathy: a Case Series Including Muscle MRI and ABCB1 Polymorphism Data","volume":"10","author":"Gupta","year":"2019","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152150_bib0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.amjmed.2016.12.006","article-title":"Risk of Colchicine-Associated Myopathy in Gout: influence of Concomitant Use of Statin","volume":"130","author":"Kwon","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2022.152150_bib0021","first-page":"185","article-title":"Neuromyopathy Caused by Long Term Colchicine Therapy","volume":"23","author":"Park","year":"2018","journal-title":"Neurol Asia"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152150_bib0022","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0014-4827(03)00034-X","article-title":"Exocytotic \u201cConstipation\u201d Is a Mechanism of Tubulin\/Lysosomal Interaction in Colchicine Myopathy","volume":"285","author":"Kuncl","year":"2003","journal-title":"Exp Cell Res"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222002013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222002013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:10:54Z","timestamp":1758733854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222002013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":22,"alternative-id":["S0049017222002013"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152150","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152150"}}